Beijing New Oriental Star Petrochemical Engineering Co Ltd

SHE:002755 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.86 Billion
CN¥13.63 Billion CNY
Market Cap Rank
#10661 Global
#2398 in China
Share Price
CN¥14.68
Change (1 day)
-0.27%
52-Week Range
CN¥14.18 - CN¥28.40
All Time High
CN¥38.01
About

Beijing Aosaikang Pharmaceutical Co., Ltd. researches, develops, manufactures, markets, and sells pharmaceuticals, fine chemicals, and health-care products in China. It offers proton pump inhibitor injections and oncology medicines, as well as APIs. The company provides its products in oncology, antibiotic, and other areas. Beijing Aosaikang Pharmaceutical Co., Ltd. was founded in 2003 and is bas… Read more

Beijing New Oriental Star Petrochemical Engineering Co Ltd (002755) - Total Liabilities

Latest total liabilities as of September 2025: CN¥1.16 Billion CNY

Based on the latest financial reports, Beijing New Oriental Star Petrochemical Engineering Co Ltd (002755) has total liabilities worth CN¥1.16 Billion CNY as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Beijing New Oriental Star Petrochemical Engineering Co Ltd - Total Liabilities Trend (2011–2024)

This chart illustrates how Beijing New Oriental Star Petrochemical Engineering Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Beijing New Oriental Star Petrochemical Engineering Co Ltd Competitors by Total Liabilities

The table below lists competitors of Beijing New Oriental Star Petrochemical Engineering Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Gs Retail
KO:007070
Korea ₩4.51 Trillion
Shenzhen Liande Automatic Equipment Co Ltd
SHE:300545
China CN¥806.34 Million
Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A
SHE:301246
China CN¥1.58 Billion
Sipef S.A.
LSE:0JSU
UK €204.86 Million
Nagacorp Ltd
PINK:NGCRF
USA $279.42 Million
Columbia Financial Inc
NASDAQ:CLBK
USA $9.86 Billion
Goldcard High-Tech Co Ltd
SHE:300349
China CN¥2.70 Billion

Liability Composition Analysis (2011–2024)

This chart breaks down Beijing New Oriental Star Petrochemical Engineering Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.72 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.36 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.26 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Beijing New Oriental Star Petrochemical Engineering Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Beijing New Oriental Star Petrochemical Engineering Co Ltd (2011–2024)

The table below shows the annual total liabilities of Beijing New Oriental Star Petrochemical Engineering Co Ltd from 2011 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥905.39 Million +76.42%
2023-12-31 CN¥513.20 Million +27.97%
2022-12-31 CN¥401.03 Million -19.35%
2021-12-31 CN¥497.24 Million -35.83%
2020-12-31 CN¥774.89 Million -34.08%
2019-12-31 CN¥1.18 Billion +5.21%
2018-12-31 CN¥1.12 Billion +296.83%
2017-12-31 CN¥281.55 Million +55.40%
2016-12-31 CN¥181.17 Million -12.93%
2015-12-31 CN¥208.08 Million -16.45%
2014-12-31 CN¥249.04 Million -9.26%
2013-12-31 CN¥274.46 Million -19.62%
2012-12-31 CN¥341.43 Million +47.56%
2011-12-31 CN¥231.39 Million --